Podcasts about Biotechnology

On this episode of The Feudal Future, hosts Joel Kotkin and Marshall Toplansky help us understand the Iranian revolution with project analyst, Mahnaz Asghari, Iranian actress Nazanin Nour,  and hematologist Montreh Tavakkoli.Mahnaz Asghari is a Sponsored Project Analyst for Chapman University University in Fullerton, CA. She is also the manager of the Feudal Future Podcast with Joel Kotkin & Marshall Toplansky. Their podcast has over 30,000 downloads worldwide.Nazanin Nour is an Iranian American actress, model and writer. She has appeared on several television films and shows, including Madam Secretary. She is one of the judges of the first season of Persia's Got Talent, the Persian spin-off of the British talent show Got Talent, produced in Stockholm, Sweden.Montreh Tavakkoli a hematology-oncology fellow at the University of Pennsylvania. She obtained her master's degree in Biotechnology from Columbia University and her medical degree from UCLA David Geffen School of Medicine, with an emphasis in Clinical & Translational Research. Her background is in preclinical drug development in leukemia/lymphoma, having contributed to the development of a leukemic stem cell-directed therapy and the personalization of an epichaperome inhibitor in acute myeloid leukemia as a Howard Hughes Medical Institute Research Fellow at the Memorial Sloan Kettering Cancer Center and as a resident at Weill Cornell. She is pursuing a career in clinical translational research in lymphoma.The California Dream:From Chapman's Center of Demographics & Policy, Joel Kotkin & Marshall Toplansky co-author the brand new report on restoring The California Dream.If you haven't downloaded the report, see it here: https://joelkotkin.com/report-restoring-the-california-dream/Visit Our Pagewww.TheFeudalFuturePodcast.comSupport Our WorkThe Center for Demographics and Policy focuses on research and analysis of global, national, and regional demographic trends and explores policies that might produce favorable demographic results over time. It involves Chapman students in demographic research under the supervision of the Center's senior staff.Students work with the Center's director and engage in research that will serve them well as they look to develop their careers in business, the social sciences, and the arts. Students also have access to our advisory board, which includes distinguished Chapman faculty and major demographic scholars from across the country and the world.For additional information, please contact Mahnaz Asghari, sponsored project analyst for the Office of Research, at (714) 744-7635 or asghari@chapman.edu.Follow us on LinkedIn:https://www.linkedin.com/company/the-feudal-future-podcast/Tweet thoughts: @joelkotkin, @mtoplansky, #FeudalFuture #BeyondFeudalismLearn more about Joel's book 'The Coming of Neo-Feudalism': https://amzn.to/3a1VV87Sign Up For News & Alerts: http://joelkotkin.com/#subscribeThis show is presented by the Chapman Center for Demographics and Policy, which focuses on research and analysis of global, national and regional demographic trends and explores policies that might produce favorable demographic results over time.

On this episode, I was joined by Joanna Gallant of JGTA. Joanna walks through: Training programs at companies that had consent decrees The difference between good training and bad GMP training Competence in knowledge work Human Error Joanna Gallant is an experienced, solutions-driven Quality and training professional who has spent more than 30 years in pharmaceutical, biotechnology, tissue culture and medical device development and manufacturing environments. Over her career, she has provided regulatory, technical, skill, and management development training support to all operations functions, as well as IT, R&D, Customer Service and senior management. Now, as a training system consultant, she works with clients to design and deliver custom training and build/remediate training systems, including in support of regulatory audit observations and commitments. Joanna has been a GMP TEA member since 2001, and now serves on the Board of Directors as an Advisor. She is one of the founders of the Biomanufacturing Certificate Program at Worcester Polytechnic Institute, and became an Adjunct Professor at the Boston University School of Medicine's Biotechnology degree program in 2011. Joanna writes a popular article series for Pharmaceutical Online on the people side of pharma & GMP, provides monthly interactive web courses through LifeScience Training Institute, and through her JGTA, LLC business, authored GMP Training Can Be Fun! along with an ever-expanding line of GMP training games and activities.

The convergence of Artificial Intelligence (AI) and biotechnology has emerged as one of the most exciting and transformative areas of science. Researchers are developing new tools and technology that could bring about breakthroughs to revolutionize the fields of medicine and health care.  In this episode, we talk with scientists who are using AI to unlock new possibilities in the search for novel drugs, cures, and treatments.

What is Mind & Matter?Whether food, drugs or ideas, what you consume influences who you become. Learn directly from the best scientists & thinkers about alive today about how your body & mind react to what they're fed.The weekly M&M podcast features conversations with the most interesting scientists, thinkers, and technology entrepreneurs alive today.Learning philosophyAt M&M, we are interested in trying to figure out how things work, not affirming our existing beliefs. We prefer consulting primary rather than secondary sources and independent rather than institutional voices. If we encounter uncomfortable truths or the evidence suggests unfashionable ideas may be valid, so be it.As the host, my aim is to help you better understand how the body & mind work by curating & synthesizing information in a way that yields science-based insights that you can choose to use or disregard in your own life. Taking ownership of your health starts with taking ownership of your information diet.I am motivated to connect the dots and distill general principles from what I learn, preferring to ask questions and play devil's advocate to debating or pushing my own viewpoint.My beliefs:Taking ownership of your health starts with taking ownership of your information diet.All knowledge is provisional and we must work hard to prevent ourselves from becoming attached to our favorite ideas & preferred conclusions.Wisdom comes from an iterative, trial-and-error process of learning and unlearning. Letting go of pre-conceived notions can be painful, but pain is information.Sometimes modern discoveries teach us we must unlearn received wisdom. Other times, modern information overload & historical chauvinism cause us to forget ancient wisdom which stills applies. The framework for learning that I embody is inspired by three Ancient Greek maxims inscribed in the Temple of Apollo at Delphi:“Γνῶθι σεαυτόν” (Know thyself)“Μηδὲν ἄγαν” (Nothing in excess)“Ἐγγύα πάρα δ Ἄτα” (Certainty brings insanity)Support the showSign up for the free weekly Mind & Matter newsletter:[https://mindandmatter.substack.com/?sort=top]Learn how you can further support the podcast: [https://mindandmatter.substack.com/p/how-to-support-mind-and-matter]

We all want to live longer, avoid metabolic diseases, think clearer, and perform better.  Today's guest, Dr. Latt Mansor, is here to help you do just that. As an expert in physiology and metabolism, he consults with elite sport, military, clinical and research organizations. He's the Research Lead at H.V.M.N. and holds a PhD in Physiology, Anatomy and Genetics from the University of Oxford, an M.A. from Columbia University and B.Sc. from the University of Nottingham in Biotechnology.  He's got a lot of knowledge to share. Listen as we discus:  Are these mistakes leading you to diabetes? [7:26] Why is reducing inflammation crucial? [20:04] How can you determine which diet is best for you? [26:42] 2 things you need to know about zone 2 cardio. [29:20] Are short and long-term memory loss reversible? [33:23] 2 ways to enhance and preserve cognitive function. [52:28] Sponsors HVMN: Ketone-IQ is clinically proven to boost mental clarity, endurance, recovery, and more. Go to hvmn.com and use code JAY20. Blokes: If you're a man over 35 you should be getting full panel blood work every 6 months IF you want to maximize your health.  Go to blokes.co/jay to get started today.  Cured Nutrition: The highest quality CBD made to help you reduce anxiety and inflammation, chill out, and sleep like a baby.  Go to curednutrition.com and use code RENEGADE.

Welcome our new host, Anelya, who covers 12 papers on the role of immune system and glia in Alzheimer's disease. The first half of this episode will focus on potential targets for the treatment of Alzheimer's disease, followed by the disease-associated inflammatory mechanisms. Part 2 will be released as a bibliography. We hope you find this episode interesting!  Sections in this episode:  Potential Therapeutic Agents (2:28)  Disease-Associated Neuroinflammatory Mechanisms (14:08) -------------------------------------------------------------- To find the numbered bibliography with all the papers covered in this episode, click here, or use the link below:https://drive.google.com/file/d/1vB80YukfRcQt6w147DhqjUgzfLzpGo8I/view?usp=share_linkTo access the folder with ALL our bibliographies, follow this link (it will be updated as we publish episodes and process bibliographies), or use the link below:https://drive.google.com/drive/folders/1bzSzkY9ZHzzY8Xhzt0HZfZhRG1Gq_Si-?usp=sharingYou can also find all of our bibliographies on our website: amindr.com. --------------------------------------------------------------Follow-up on social media for more updates!Twitter: @AMiNDR_podcastInstagram: @AMiNDR.podcastFacebook:  AMiNDR  Youtube: AMiNDR PodcastLinkedIn: AMiNDR PodcastEmail: amindrpodcast@gmail.com  -------------------------------------------------------------- Please help us spread the word about AMiNDR to your friends, colleagues, and networks! And if you could leave us a rating and/or review on your streaming app of choice (Apple Podcasts, Spotify, or wherever you listen to the podcast), that would be greatly appreciated! It helps us a lot and we thank you in advance for leaving a review! Don't forget to subscribe to hear about new episodes as they come out too. Thank you to our sponsor, the Canadian Consortium of Neurodegeneration in Aging, or CCNA, for their financial support of this podcast. This helps us to stay on the air and bring you high quality episodes. You can find out more about the CCNA on their website: https://ccna-ccnv.ca/. Our team of volunteers works tirelessly each month to bring you every episode of AMiNDR. This episode was scripted and hosted by Anelya Gandy, edited by Michelle Grover, and reviewed Elyn Rowe, Ellen Koch, and Anusha Kamesh. The bibliography and wordcloud were made by Lara Onbasi (www.wordart.com). Big thanks to the sorting team for taking on the enormous task of sorting all of the Alzheimer's Disease papers into episodes each month. For November 2022, the sorters were Sarah Louadi, Eden Dubchak, Ben Cornish, Christy Yu, Dana Clausen, Kevin Nishimura, Anelya Gandy, Salodin Al-Achkar, Ellen Koch, and Elyn Rowe. Also, props to our management team, which includes Sarah Louadi, Ellen Koch, Naila Kuhlmann, Elyn Rowe, Anusha Kamesh, Lara Onbasi, Joseph Liang, and Judy Cheng, for keeping everything running smoothly.Our music is from "Journey of a Neurotransmitter" by musician and fellow neuroscientist Anusha Kamesh; you can find the original piece and her other music on soundcloud under Anusha Kamesh or on her YouTube channel, AKMusic.   https://www.youtube.com/channel/UCMH7chrAdtCUZuGia16FR4w   -------------------------------------------------------------- If you are interested in joining the team, send us your CV by email. We are specifically looking for help with sorting abstracts by topic, abstract summaries and hosting, audio editing, creating bibliographies, and outreach/marketing. However, if you are interested in helping in other ways, don't hesitate to apply anyways.  --------------------------------------------------------------*About AMiNDR: *  Learn more about this project and the team behind it by listening to our first episode: "Welcome to AMiNDR!" 

After being diagnosed with breast cancer at 30 and going through 8 rounds of chemotherapy, Alina Mehrle was left with dehydrated and fragile skin. The challenges with restoring her youthful and healthy skin inspired her to launch her own skincare brand, AMEŌN, which balances nature and the achievements of modern science. Founder story: from architecture to beauty, her courageous and inspiring story to building a brand. AMEŌN skincare: She spent 2 years developing products that nourish the skin and tap into healing mineral energy, micronutrients, and biotech.Chemotherapy's effects on the skin and her recommendations for skin and beautyCryotherapy: the benefits of skin icing and how to use the Frozen Essence at-homeEthics of using “natural ingredients” and why her scientists stand behind “naturally derived.”

Ellen brings you summaries of 8 abstracts from November 2022, all about functional connectivity and imaging in the context of Alzheimer's disease. There are a variety of brain regions covered in today's episode, including cortical regions, subcortical structures, and the hippocampus. Spanning studies in both humans and animals, this episode is sure to have something of interest to you and your research!  Sections in this episode:  Cortical regions (3:39)  Subcortical forebrain regions (8:57)  Hippocampus (14:30) -------------------------------------------------------------- To find the numbered bibliography with all the papers covered in this episode, click here, or use the link below:https://drive.google.com/file/d/1vpN33jcSgeoS-9QrcNiSJaYDFQY23CeW/view?usp=share_linkTo access the folder with ALL our bibliographies, follow this link (it will be updated as we publish episodes and process bibliographies), or use the link below:https://drive.google.com/drive/folders/1bzSzkY9ZHzzY8Xhzt0HZfZhRG1Gq_Si-?usp=sharingYou can also find all of our bibliographies on our website: amindr.com. --------------------------------------------------------------Follow-up on social media for more updates!Twitter: @AMiNDR_podcastInstagram: @AMiNDR.podcastFacebook:  AMiNDR  Youtube: AMiNDR PodcastLinkedIn: AMiNDR PodcastEmail: amindrpodcast@gmail.com  -------------------------------------------------------------- Please help us spread the word about AMiNDR to your friends, colleagues, and networks! And if you could leave us a rating and/or review on your streaming app of choice (Apple Podcasts, Spotify, or wherever you listen to the podcast), that would be greatly appreciated! It helps us a lot and we thank you in advance for leaving a review! Don't forget to subscribe to hear about new episodes as they come out too. Thank you to our sponsor, the Canadian Consortium of Neurodegeneration in Aging, or CCNA, for their financial support of this podcast. This helps us to stay on the air and bring you high quality episodes. You can find out more about the CCNA on their website: https://ccna-ccnv.ca/. Our team of volunteers works tirelessly each month to bring you every episode of AMiNDR. This episode was scripted, hosted, and edited by Ellen Koch, and reviewed by Anusha Kamesh. The bibliography was created by Anjana Rajendran and the wordcloud was made by Lara Onbasi (www.wordart.com). Big thanks to the sorting team for taking on the enormous task of sorting all of the Alzheimer's Disease papers into episodes each month. For November 2022, the sorters were Sarah Louadi, Eden Dubchak, Ben Cornish, Christy Yu, Dana Clausen, Kevin Nishimura, Anelya Gandy, Salodin Al-Achkar, Ellen Koch, and Elyn Rowe. Also, props to our management team, which includes Sarah Louadi, Ellen Koch, Naila Kuhlmann, Elyn Rowe, Anusha Kamesh, Lara Onbasi, Joseph Liang, and Judy Cheng, for keeping everything running smoothly.Our music is from "Journey of a Neurotransmitter" by musician and fellow neuroscientist Anusha Kamesh; you can find the original piece and her other music on soundcloud under Anusha Kamesh or on her YouTube channel, AKMusic.   https://www.youtube.com/channel/UCMH7chrAdtCUZuGia16FR4w   -------------------------------------------------------------- If you are interested in joining the team, send us your CV by email. We are specifically looking for help with sorting abstracts by topic, abstract summaries and hosting, audio editing, creating bibliographies, and outreach/marketing. However, if you are interested in helping in other ways, don't hesitate to apply anyways.  --------------------------------------------------------------*About AMiNDR: *  Learn more about this project and the team behind it by listening to our first episode: "Welcome to AMiNDR!" 

A ‘memory hole' embodies the concept of censorship and rewriting the past in all of its authoritarian glory. But there are different forms of memory holes, and they aren't just rabbit holes or worm holes. One such abyss is time, a relative thing few of us recognizes as probably the greatest censor of them all. How often do we forget what we did today, let alone last month, year, or a decade ago. On this episode we will open our vast paper archive and explore some of the stories that have been lost to recent history. Who knows what we will find. Tune in for a fun and explorative time. It's all improv.

What does the Church teach about the use of CRISPR gene editing technology and other advances in biotechnology? In this part 2 of 2, Dr. Brett Salkeld opens a conversation with Sr. Zoe Bernatsky, professor of Moral, Spiritual, and Pastoral Theology at Newman Theological College in Edmonton, Alberta.

In this episode of GODMODE™: Win or Win Bigger, William Lam and Brady Edwards discuss with Dr. Arup Sen the biotechnology side of health and nutrition to improve the min and create a better body and soul.Dr. Sen has 35+ years in research and executive management positions at biotechnology and pharmaceutical companies, negotiated and managed licenses and joint ventures with J&J, Biomet, GCC, Tokuyama Soda of Japan, Eastman Kodak, and Sandoz/Novartis.His work during the past decade led to the invention of proprietary technologies that produce unique water-soluble minerals, and micronutrients, including phytochemicals. Arup was awarded a Ph.D. in biochemistry from Princeton University and is a former faculty member at the National Cancer Institute (Bethesda, Maryland) and at the Scripps Research Institute (La Jolla, California) focused on cancer research.Dr. Sen is the inventor of five (5) US patents and numerous international patents and pending patent applications in the fields of cancer therapeutics, bone repair biologics, and devices and diagnostics.---HIGHLIGHTS:How biotechnology side of health and nutrition can improve the mind and ultimately create a better body and soulThe process of healthy agingWhy should you be interested in the new formulation of supplementation?---TIME STAMPS:00:00 - Prelude1:15 - Introduction to Dr. Arup Sen04:00 - Introduction to the biotechnology side of health and nutrition to improve the mind and create a better body and soul06:45 - Combine the strength and beauty of the body with the upgrading of the mind and create a better humanity 10:30 - Target what can be done and that is by developing supplements13:00 - The different types of formulations in the making19:00 - Where did the formulation of the supplements begin?24:00 - The process of healthy aging31:00 - Why should people be interested in the new formulation of supplements35:45 - How do we know the dosage of what to take to fully optimize our bodies?37:30 - Who will benefit more from this supplementation?47:00 - What will be the goal for the formulation and technology for the supplementation?53:30 - What do people need to do to prepare for this technology?01:03:00 - How can you invest in this biotech project?01:07:35 - How will this technology benefit mankind?01:10:58 - ENDThank you for listening to GODMODE™: Win or Win BiggerIf you are interested in UPGRD Your Mind, visit us at: https://upgrd.com to book a call with one of our team members.

This episode: New techniques allow specific modifications in certain members of a complex community of microbes, without isolating them in pure culture first! Download Episode (11.5 MB, 16.7 minutes) Show notes: Microbe of the episode: Tomato golden mosaic virus News item Takeaways The technology for understanding and manipulating microbial genetics has come a long way in a short time. It used to take years even to sequence a small genome, and now thousands can be sequenced in just a few days. The technology to change and even create genetic sequences is also much further advanced now than just a few decades ago. But still, many analyses and modifications require a pure culture of a microbe to carry out. This study tested a method for modification of single or multiple species in a community of many. The method allows for identification of which species were successfully modified in targeted ways, and can allow the modified species to be extracted and studied individually.   Journal Paper: Rubin BE, Diamond S, Cress BF, Crits-Christoph A, Lou YC, Borges AL, Shivram H, He C, Xu M, Zhou Z, Smith SJ, Rovinsky R, Smock DCJ, Tang K, Owens TK, Krishnappa N, Sachdeva R, Barrangou R, Deutschbauer AM, Banfield JF, Doudna JA. 2022. Species- and site-specific genome editing in complex bacterial communities. 1. Nat Microbiol 7:34–47.   Other interesting stories: Microbes that degrade plastic may be increasing in response to plastic pollution Algae in ocean communicate with each other using fluorescence   Email questions or comments to bacteriofiles at gmail dot com. Thanks for listening! Subscribe: Apple Podcasts, Google Podcasts, Android, or RSS. Support the show at Patreon, or check out the show at Twitter or Facebook.

Dr. Al-Adhami, CEO, envisioned and developed the technology behind the Jiddu, and founded Astek after winning multiple entrepreneurship awards, while completing his PhD in Mechanical Engineering. The company is currently located in University Of Maryland's biopark. We discuss his story from immigrant to entrepreneur and highlight the growing biotechnology sector in Baltimore.

In this episode, Anusha guides you through 11 papers that were published in November of 2022. These papers study the efficacy of treatments targeting neuroprotection in Alzheimer's Disease models. Tune in if you want to be on the cutting edge of drug discovery and development in the field of AD.  Sections in this episode:  Drug Discovery and Development of Novel Therapeutics (3:49)  Testing Existing Compounds (17:27) -------------------------------------------------------------- To find the numbered bibliography with all the papers covered in this episode, click here, or use the link below:https://drive.google.com/file/d/1osewDiGUB7cy55VgU6YdG2f4dyqR4mvT/view?usp=share_linkTo access the folder with ALL our bibliographies, follow this link (it will be updated as we publish episodes and process bibliographies), or use the link below:https://drive.google.com/drive/folders/1bzSzkY9ZHzzY8Xhzt0HZfZhRG1Gq_Si-?usp=sharingYou can also find all of our bibliographies on our website: amindr.com. --------------------------------------------------------------Follow-up on social media for more updates!Twitter: @AMiNDR_podcastInstagram: @AMiNDR.podcastFacebook:  AMiNDR  Youtube: AMiNDR PodcastLinkedIn: AMiNDR PodcastEmail: amindrpodcast@gmail.com  -------------------------------------------------------------- Please help us spread the word about AMiNDR to your friends, colleagues, and networks! And if you could leave us a rating and/or review on your streaming app of choice (Apple Podcasts, Spotify, or wherever you listen to the podcast), that would be greatly appreciated! It helps us a lot and we thank you in advance for leaving a review! Don't forget to subscribe to hear about new episodes as they come out too. Thank you to our sponsor, the Canadian Consortium of Neurodegeneration in Aging, or CCNA, for their financial support of this podcast. This helps us to stay on the air and bring you high quality episodes. You can find out more about the CCNA on their website: https://ccna-ccnv.ca/. Our team of volunteers works tirelessly each month to bring you every episode of AMiNDR. This episode was scripted, hosted and edited by Anusha Kamesh, and reviewed by Naila Kuhlmann. The bibliography and wordcloud were created by Lara Onbasi (www.wordart.com). Big thanks to the sorting team for taking on the enormous task of sorting all of the Alzheimer's Disease papers into episodes each month. For November 2022, the sorters were Sarah Louadi, Eden Dubchak, Ben Cornish, Christy Yu, Dana Clausen, Kevin Nishimura, Anelya Gandy, Salodin Al-Achkar, Ellen Koch, and Elyn Rowe. Also, props to our management team, which includes Sarah Louadi, Ellen Koch, Naila Kuhlmann, Elyn Rowe, Anusha Kamesh, Lara Onbasi, Joseph Liang, and Judy Cheng, for keeping everything running smoothly.Our music is from "Journey of a Neurotransmitter" by musician and fellow neuroscientist Anusha Kamesh; you can find the original piece and her other music on soundcloud under Anusha Kamesh or on her YouTube channel, AKMusic.   https://www.youtube.com/channel/UCMH7chrAdtCUZuGia16FR4w   -------------------------------------------------------------- If you are interested in joining the team, send us your CV by email. We are specifically looking for help with sorting abstracts by topic, abstract summaries and hosting, audio editing, creating bibliographies, and outreach/marketing. However, if you are interested in helping in other ways, don't hesitate to apply anyways.  --------------------------------------------------------------*About AMiNDR: *  Learn more about this project and the team behind it by listening to our first episode: "Welcome to AMiNDR!" 

Subscriber-only episodeDr. Herman Weiss graduated Summa Cum Laude from Ramapo College of NJ with a degree In Philosophy and pursued a medical degree at The Ohio State University College of Medicine. After achieving his degree, he trained in Women's Health at Einstein College of Medicine Montefiore Medical Center/Jacobi Hospital in the Bronx, NY. He joined a vibrant practice in Long Island for eight-plus years and continued to have an entrepreneurial spirit and went back to school to complete his MBA from George Washington University. He co-founded and was the Chief Medical officer of a Biotech medical device company called FibroControl that dealt with minimally invasive techniques for women's health issues. He was recruited to become the Global Medical Director for Women's Health at Teva Pharmaceuticals an international giant in the pharma space. After five years at Teva he relocated to Boston where he was brought in to Juniper Pharmaceuticals to lead the Medical Affairs and Clinical Development departments, as VP. From there he was brought in as Interim CEO of Todos Medical focused on innovative solutions for early cancer detection. He developed, founded and launched the Master's Program for Commercialization and Entrepreneurship for Biotechnology at Yeshiva University in NYC. There he taught Fundamentals of Biotechnology to the Master students. He continued to teach various entrepreneurial courses at YU including Principles of Entrepreneurship and Founders Dilemmas. He recently launched his own startup focused on bringing medicine back to disease prevention and health maintenance specifically as it relates to Women's Health, where he is the CEO of Provation Life.Provation Life Supplement _ Weight Loss PCOS & More Amazon Website -https://provationlife.com/Education- https://education.provationlife.com/ Support the showAre YOU Feeling Stressed, Tired & Overall imbalanced? Enjoy a Free Mindful Steps!!https://mindfullyintegrative.mykajabi.com/pl/2147589400 Lets Work on Your Optimal Wellness Journey!Sign Up For Discovery Call://calendly.com/drdamarisg/30minEnjoy the Show and Get Bonus Episodes Subscribe For Just $4 a month Enjoy some of Our FREE Resources HereJoin Our Mindfully Integrative Private Facebook CommunityGet 15% off Pharmaceutical Grade Full Script Vitamins & Supplements

What does the Church teach about the use of CRISPR gene editing technology and other advances in biotechnology? In this part 1 of 2, Dr. Brett Salkeld opens a conversation with Sr. Zoe Bernatsky, professor of Moral, Spiritual, and Pastoral Theology at Newman Theological College in Edmonton, Alberta. Show Snippet: "It's relatively straightforward to change a single gene, and if you've ever watched someone suffer with Huntington's, you would say, "I can, I can stop that by changing a single gene? I will take it. Thank you." It's a good example because it's a straightforward one (but) There's lots of other potential things that might be done that are much more complex when there's more than one gene, and then the question of unintended consequences starts to compound." 

Algenesis is two companies in one, a biotechnology innovator and footwear maker. Making a new, sustainable material often requires the inventor to prove its utility before big companies will embrace it. Join the conversation for a story of discovery and finding a practical application to prove the value of a plant-based, compostable bioplastic foam. Stephen Mayfield, a professor of Biology at UC San Diego and director of the California Center for Algae Biotechnology, invented Soleic, an algae-based rubbery foam material that can be used in footwear, surfboards and other products in the place of petroleum-based polyurethane foam. He launched Algenesis, a biotechnology-based materials science company to commercialize the Soleic.But shoe companies did not come running to use Soleic, which biodegrades completely in sea water and compost piles. Along with Algenisis president Tom Cooke, a footwear and apparel industry veteran who had worked for Reef and Vans, Steve launched Blueview Footwear, maker of the world's first compostable shoe. Steve and Tom join me today to talk about the evolution of Algenesis and Blueview, as well as the many materials Soleic could replace across a variety of product categories. The companies have also developed compostable, plant-based fabrics and a bioplastic waterproofing technology that biodegrades into organic material in a home compost pile. You can learn more about Blueview Footwear at https://blueviewfootwear.com/ and its parent company Algenesis Materials at https://www.algenesismaterials.com/

Ellen kicks off the November 2022 series with 11 papers about synaptic transmission and neurotransmitters in Alzheimer's disease. Hear about glutamate, acetylcholine, synaptic proteins, and more in this jam-packed episode!  Sections in this episode:  Glutamate and Acetylcholine (4:01)  GABA neurons (10:52)  Neuron Excitability (12:15)  Synaptic Proteins (15:10)  Neuro-Immuno-Endocrine System (21:45) -------------------------------------------------------------- To find the numbered bibliography with all the papers covered in this episode, click here, or use the link below:https://drive.google.com/file/d/1dELth-9F_TVyUTuxPmuIVYKM1MgCuIEf/view?usp=share_linkTo access the folder with ALL our bibliographies, follow this link (it will be updated as we publish episodes and process bibliographies), or use the link below:https://drive.google.com/drive/folders/1bzSzkY9ZHzzY8Xhzt0HZfZhRG1Gq_Si-?usp=sharingYou can also find all of our bibliographies on our website: amindr.com. --------------------------------------------------------------Follow-up on social media for more updates!Twitter: @AMiNDR_podcastInstagram: @AMiNDR.podcastFacebook:  AMiNDR  Youtube: AMiNDR PodcastLinkedIn: AMiNDR PodcastEmail: amindrpodcast@gmail.com  -------------------------------------------------------------- Please help us spread the word about AMiNDR to your friends, colleagues, and networks! And if you could leave us a rating and/or review on your streaming app of choice (Apple Podcasts, Spotify, or wherever you listen to the podcast), that would be greatly appreciated! It helps us a lot and we thank you in advance for leaving a review! Don't forget to subscribe to hear about new episodes as they come out too. Thank you to our sponsor, the Canadian Consortium of Neurodegeneration in Aging, or CCNA, for their financial support of this podcast. This helps us to stay on the air and bring you high quality episodes. You can find out more about the CCNA on their website: https://ccna-ccnv.ca/. Our team of volunteers works tirelessly each month to bring you every episode of AMiNDR. This episode was scripted, hosted, and edited by Ellen Koch, and reviewed by Anelya Gandy and Anusha Kamesh. The bibliography and wordcloud were created by Lara Onbasi (www.wordart.com). Big thanks to the sorting team for taking on the enormous task of sorting all of the Alzheimer's Disease papers into episodes each month. For November 2022, the sorters were Sarah Louadi, Eden Dubchak, Ben Cornish, Christy Yu, Dana Clausen, Kevin Nishimura, Anelya Gandy, Salodin Al-Achkar, Ellen Koch, and Elyn Rowe. Also, props to our management team, which includes Sarah Louadi, Ellen Koch, Naila Kuhlmann, Elyn Rowe, Anusha Kamesh, Lara Onbasi, Joseph Liang, and Judy Cheng, for keeping everything running smoothly.Our music is from "Journey of a Neurotransmitter" by musician and fellow neuroscientist Anusha Kamesh; you can find the original piece and her other music on soundcloud under Anusha Kamesh or on her YouTube channel, AKMusic.   https://www.youtube.com/channel/UCMH7chrAdtCUZuGia16FR4w   -------------------------------------------------------------- If you are interested in joining the team, send us your CV by email. We are specifically looking for help with sorting abstracts by topic, abstract summaries and hosting, audio editing, creating bibliographies, and outreach/marketing. However, if you are interested in helping in other ways, don't hesitate to apply anyways.  --------------------------------------------------------------*About AMiNDR: *  Learn more about this project and the team behind it by listening to our first episode: "Welcome to AMiNDR!" 

In this month's episode of the American Blue Economy Podcast, host Rear Admiral Tim Gallaudet, PhD, US Navy (ret) explores the many benefits of biotechnology to the American Blue Economy, Drawing from his recent article in Real Clear Science, 7 Technologies Revolutionizing Our Understanding of the Ocean | RealClearScience, he is assisted by 4 of his former colleagues from the National Oceanic and Atmospheric Administration (NOAA). These exceptional experts include: Dr. Kelly Goodwin, ‘Omics lead for NOAA's Office of Oceanic and Atmospheric Research; Dr. Luke Thompson, Associate Research Professor with NOAA's Northern Gulf Institute at Mississippi State University and NOAA's Atlantic Oceanographic and Meteorologic Laboratory; Dr. Jeanette Davis, a Marine Microbiologist, bestselling author, and Policy Advisor to the Deputy Undersecretary at NOAA; and Dr. Krista Nichols, Genetics and Evolution Program Manager at NOAA's Northwest Fisheries Science Center and NOAA's Omics Working Group Vice Chair. Be ready to be marveled by the magnificent field of marine microbiology in the American Blue Economy!

This episode is sponsored by the Black & Veatch NextGen Ag Team. Learn more about Black and Veatch at https://www.bv.com Edward Shenderovich is co-founder and CEO of Synonym Biotechnologies. Before Synonym, Edward was the Executive Chairman and co-founder of Knotel, a leading flexible office company (acquired by Newmark), founding and managing partner of Kite Ventures, a global venture investment company, and a founding executive of SUP Media, where he oversaw the company's strategic development, including the rollout of LiveJournal globally. Previously, he was a co-founder and CEO of Quantum Art, a content management software provider, and a co-founder of Merchantry, a New York-based provider of online marketplace infrastructure (acquired by Tradeshift). Edward has served on the boards of directors of a number of successful companies, including Tradeshift, Delivery Hero, Plated, Domo, and others. He started his career as an Industry Analyst at Silicon Valley Bank. Edward is a graduate of UC Berkeley and a Fellow at Universita Cattolica del Sacro Cuore. Check out Capacitor, The free worldwide database of biomanufacturing capacity at https://capacitor.bio/ --- Support this podcast: https://anchor.fm/futurefoodshow/support

GUEST BIO: Dr. Latt Mansor holds a PhD in Physiology, Anatomy and Genetics from the University of Oxford, where his research focused on the metabolism of the type 2 diabetic heart in hypoxia. He also holds an M.A. (Columbia University) and B.Sc. (Hons) (University of Nottingham) in Biotechnology. He is a world expert in physiology and metabolism, and consults with elite sport, military, clinical and research organizations.- **Principal Investigator of a $6 million military contract on exogenous ketones** - Dr. Mansor is the Research Lead at H.V.M.N., overseeing all of the company's research efforts and collaborations with universities and research institutions. Currently, he is the principal investigator of the $6 million U.S. Special Operations Command (USSOCOM) contract awarded to H.V.M.N by the Department of Defense, with a targeted completion date of October 2022. This project focuses on operator performance in hypoxia (low oxygen environment), which has applications for soldier performance at altitude, in mountains, on fighter jets, and, potentially one day, in space. - **Interest and previous research in diabetes and cardiovascular disease** - His interest in diabetes and cardiovascular disease stemmed from the high prevalence of those diseases in both his parents' families. He then developed interests in metabolism and exercise during his undergraduate years as he created a mathematical model of adipose tissue (fat) metabolism for his final year project. He then researched using exercise as an intervention for sarcopenia, muscle loss due to aging, for his Master's thesis. Along his journey of acquiring more knowledge on metabolic health and physiology, he started applying his findings in his daily life to strive for better health and to prove that genetic disposition to chronic diseases is not the entire equation. Epigenetics and lifestyle choices have been proven to change the trajectory of disease progression or in some cases, even reverse it! - **Personal health journey from smoking cessation to weight loss** - The turning point was when he realized that he was only 22 years old and already living an extremely unhealthy lifestyle. Weighing over 200 lbs, never exercised unless he was forced to and a heavy smoker that smoked 30-40 cigarettes a day to boot! The more knowledge he acquired, the more he understands that he is doing injustice to his body and is definitely not helping his genetic disposition towards diabetes and cardiovascular disease so he turned his life around, quit smoking, started with only jogging around the park to joining a gym, quit drinking soda every day and started eating healthy. It was not an easy journey but it has certainly been a self-discovery and rewarding journey nonetheless. He is now committed to finding new ways to make his insights more relatable and accessible to the general public.Although his education was primarily in health sciences, Latt always believed that collaborative efforts between science and business have more potential to create an impact in improving people's lives than each on its own. SHOW NOTES: 

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with Raman Sehgal for a special lookback episode on the topic of diversity in the life sciences space. This week's episode features excerpts from conversations with; Barbara Morgan (Lubrizol at time of recording), now Global Vice President, Pharma and Biotechnology at Kerry discussing; gender diversity and the network of women supporting each other in their roles. Tia Lyles-Williams, founder & CEO at LucasPye Bio discussing; the recent political climate and how that has affected steps forward in diversity and inclusion. Jeff Dill, CEO at Vynamic discussing; the importance of diversity at his organization, and what they have put in place to ensure EDI goals are being achieved. Andrew Moore, General Manager at Pfizer Center One discussing; his experience as a person of color in the sector, and how the conversation has changed in his time. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We'd also appreciate a positive rating! Molecule to Market is sponsored and funded by ramarketing. An international content, design and digital agency that helps companies in life sciences, get noticed.

We need to scale. But how? The biotech space is will go through some growing pains. Find out about scalability issues like bioreactor capacity, the supply of inputs, and the lack of brains. As well as lessons we can learn from vertical farming companies that are already a step or two further down the line. Join me for a chat with Elliot Schwartz, he is the Lead Scientist for Cultivated Meat at The Good Food. If you are not familiar with precision fermentation check out t episode 1 of this season where we explain a bunch of the terms. LINKS Check out our supporter of this season ProVeg Incubator and their 12-month incubator program: https://provegincubator.com/ More info and links to resources on https://redtogreen.solutions/ Connect with Marina Schmidt https://www.linkedin.com/in/schmidt-marina/ Check out our supporter of this season, FoodLabs, and their Climate Program: https://www.foodlabs.com/ More info and links to resources on https://redtogreen.solutions/ Hashtags for this episode Bioreactor capacity Fermentor Scaling Biotechnology Scaling food technology Cultured Meat Cultivated Meat Cell-based meat Lab-grown meat Future of cultured meat Hashtags for this season Biotechnology in food Food Tech Food Technology Future of Food Food Innovation What is biotechnology food Food biotechnology examples Food biotechnology startups Biotechnology food companies Biotech food in usa Food biotechnology examples Editor's note: this episode was lengthened with a ProVeg shout out at minute 8:30

In each episode, Paddy Dhanda deep dives into a new human Superpower and practical advice on how you can apply it immediately. ⚡️ Ready for a Fresh Start? Tips for Making Large Life Pivots Life is full of unexpected twists and turns, and sometimes it takes a major pivot to get back on track. Making large life pivots can be daunting, but it can also be incredibly rewarding. In this episode, we'll explore the process of making a big life change, from the initial steps to the ultimate reward. Whether you're considering a career change, a lifestyle shift, or something else entirely, this episode will provide the information and resources you need to make the most of your life pivot. Leah Elson (Clinical Development Scientist & Author) Leah is an academically-published scientist and charismatic science communicator. Her 14-year career in medical research has included the fields of orthopedics, novel biotechnology, oncology, and neuroscience. She studied pre-medical sciences at Harvard University, and has earned graduate degrees in the fields of Biotechnology (the Johns Hopkins University), as well as Global Health & Epidemiology (Keck School of Medicine at the University of Southern California). She is pursuing her doctoral degree in molecular biology. Leah is passionate about inspiring adults to re-discover their childlike awe for the world around them. Book: There Are (No) Stupid Questions... in Science (release date: June 27, 2023) Social media link: Instagram/TikTok @gnarlybygnature Website: www.leahelson.com

In today's episode of the Master Delegator Podcast, Kristy Yoder sat down with the Chief Operating Officer of Teamwork, John O'Mara. Teamwork is an effective online tool for team & project management for businesses built for scaling client work, delivering tasks on time and on budget, eliminating workload chaos, and understanding profitability.Join them and listen to this episode as they talk about teamwork, delegation, scaling the business, and the importance of relationships in running a business.Episode Highlights:04:55: Introduction of John O'Mara and what is Teamwork07:56: The history of Teamwork11:12: Struggles of becoming a COO at Teamwork21:51: Teamwork at the pandemic year22:49: Customers are the center of the business27:23: Creating & building relationships with customers31:38: Why leaders need an Executive Assistant34:25: John's support system39:44: Hiring an Executive Assistant remotely41:10: Delegation is key to your success (Surrounding yourself with capable people)41:40: How to successfully delegate in your business49:40: Importance of good and bad experience53:43: Buying the domain called teamwork.com About John O'MaraJohn is an accomplished C-level executive with a broad range of International Finance and General Management experience in the SaaS, Biotechnology, Software, Professional Services, and Manufacturing Sectors. He's also an experienced international leader, decision maker and business partner with advanced skills in the areas of debt and equity fundraising, commercial finance, strategy development, international change programs, company start-up, IPO, business sale, and merger & acquisition projects.Learn more about him and Teamwork here:Website: https://www.teamwork.com/ LinkedIn: https://www.linkedin.com/in/john-o-mara-62b4a6b/Facebook: https://www.facebook.com/TeamworkHQInstagram: https://www.instagram.com/teamworkhq/ Are you in need of any assistance? Are you tired and running out of time? It's time to start looking for a virtual assistant! Learn how to get your freedom and life back by visiting Smartvirtualassistants.comBe part of our Facebook community page for entrepreneurs who want to become a master delegator. Do you want to learn how to hire a virtual assistant? Access our free training. Want to know how to delegate effectively? Get access to our mini-course!

Tia Lyles-Williams, D.Sc. is a Two-Time Life Science Start-Up Founder – Founder & CEO of LucasPye BIO, a Contract Development Manufacturing Organization (CDMO); and Founder & CEO of HelaPlex, the 1st Commercial Life Science Accelerator for Seed-Level Life Science Start-Ups and Virtual Biotechnology Companies. In fact, LucasPye BIO is a strategic partner of Thomas Jefferson University's Jefferson Institute for Bioprocessing (JIB). Dr. Lyles-Williams is the 1st African American Queer Woman to own and lead a biopharmaceutical manufacturing company – 68 years after the 1st African American Man, Dr. Percy Lavon Julian with his company, Julian Laboratories, Inc. in Chicago, IL. She received her Bachelor of Science in Biology from Howard University, Master of Science in Entertainment Business from Full Sail University, and a Master of Science in Regulatory Science from University Southern California. On May 12, 2022, Dr. Lyles-Williams was conferred as an Honorary Doctorate in The Sciences from the Sidney Kimmel Medical College at Thomas Jefferson University in Philadelphia, PA. Most recently, Dr. Lyles-Williams participated as a panelist at The White House discussion Biotechnology and the Bioeconomy in the U.S. via the U.S. White House Summit on Biotechnology and Biomanufacturing. Link: https://youtu.be/U2bdz5HE1zM Dr. Lyles-Williams has been working in the biotechnology / biopharmaceutical industry for 22+ years – including formerly interning at the National Institutes of Health (NIH) as well as a former contractor at Walter Reed Army Institute of Research (WRAIR in Silver Spring, MD). Her former employers include Human Genome Sciences, Inc. (now GSK) – Rockville, MD; Amgen, Inc. – Thousand Oaks, CA; Baxter BioScience (now Takeda) – Thousand Oaks, CA; Avid Bioservices – Tustin, CA; Lonza Pharma & Biotech – Portsmouth, NH; and Jazz Pharmaceuticals, PLC – Philadelphia, PA. Find Dr. Tia Online! https://www.linkedin.com/in/tia-l-596a484/ https://www.lucaspyebio.com/ If you're enjoying Entrepreneur's Enigma, please give us a review on the podcast directory of your choice. We're on all of them and these reviews really help others find the show. Also, if you're getting value from the show and want to buy me a coffee, go to the show notes to get the link to get me a coffee to keep me awake, while I work on bringing you more great episodes to your ears. →  https://gmwd.us/buy-me-a-coffee Follow Seth Online: Seth | Digital Marketer (@s3th.me) • Instagram: Instagram.com/s3th.me Seth Goldstein | LinkedIn: LinkedIn.com/in/sethmgoldstein Seth on Mastodon: https://masto.ai/@phillycodehound Learn more about your ad choices. Visit megaphone.fm/adchoices

Last December, a United Airlines' flight from Chicago to Washington DC was the first ever passenger flight powered with 100% sustainable aviation fuel. The achievement demonstrated the potential for the aviation sector to reduce its carbon footprint. Our guests in this episode each played a key role in in helping the airline reach this exciting milestone.

Dan Budwick is the founder and CEO of 1AB Media, a communications agency focused on early stage Biotechnology companies – helping them tell stories and build their brands. In this episode, he shares the secrets of what it takes for Biotech companies to get investors and the public behind them, as these companies seek to break the boundaries of science and pursue cures and treatments in a world ridden with failure. Learn more about Mark:-        Twitter-        LinkedIn-        1AB MediaTop 3 Lessons:1.     Withstand inevitable failures by building a trusted brand 2.     Simplify the scientific story to reach a broader audience3.     Invest in the compounding power of relationships Ways I can help you:Subscribe to Healthy Brand Mondays: Leverage brand thinking to accelerate your growthDownload free guides and tools: Learn from my years of experience as a brand strategistWork with me: Be a podcast guest or hire my services for your brand LinkedIn TwitterInstagramTikTokYouTubeGet more from Healthy Brands: Subscribe to Healthy Brand Mondays: 1 branding lesson every Monday in your inbox Download messaging toolkit and other free brand strategy guides Work with me Connect with Howie: LinkedIn Twitter Instagram TikTok YouTube

Dr. Ashley Walker returns to the podcast today to talk about being a pharmacist, an entrepreneur, and an advocate.  She was also featured in my Back-to-School Series in August 2022 (Episode 173), which promoted her Speed Signing (American Sign Language) Classes and OTC Hearing Aids Class.   Ashely is deaf, but you will hear her speaking voice in this episode.  This interview is also available as a YouTube video. Click here for the YouTube link.  *Updated subtitles will be added after the video has been published. Bio (January 2023) Dr. Ashley R Walker is a pharmacist, entrepreneur, and an advocate. Dr. Walker holds a Doctor of Pharmacy degree from Xavier University of Louisiana and a Bachelors of Science in Biotechnology from Rochester Institute of Technology. She has been a pharmacist for 7 years and recently transitioned into full time entrepreneurship. Prior to her transition, she has had experience in retail pharmacy, hospital pharmacy, and long term care pharmacy. Her recent transition into full time entrepreneurship has led to the birth of her business Med Max Consulting, LLC. Under this business, Dr. Walker can advocate for members of the deaf and hard of hearing community as well as offer medication counseling services to help this unique community maximize and optimize their medication therapy. Since her high school years, Dr. Walker has been an advocate for members of the deaf and hard-of-hearing community. She spends time speaking to students in elementary, middle, and high school encouraging them to never let their hearing loss be a reason not to dream big and go after their dreams. As a deaf person herself, she also helps business owners and healthcare professionals make their businesses/practices inclusive to members of this unique community. Dr. Walker enjoys reading, traveling, going on walks with her family, and attending festivals. With her personal experiences as a deaf pharmacist and advocate for the deaf and hard-of-hearing community she aims to remind the world that deafness should not be viewed as a DIS-ability but rather a UNIQUE-ability. Thank you for listening to episode 197 of The Pharmacist's Voice ® Podcast! To read the full show notes, visit https://www.thepharmacistsvoice.com.  Click on the podcast tab, and search for episode 197. Subscribe to or Follow The Pharmacist's Voice Podcast! Apple Podcasts Google Podcasts Spotify Amazon/Audible

Anusha brings you another episode of AMiNDR featuring literature published in October 2022. In this episode, you'll hear 12 papers that converge on the topic of treatments that target neurotoxicity. This episode is poised to leave you feeling hopeful about the various treatment avenues to be pursued so be sure to tune in!  Sections in this episode:  Targeting Neurotoxicity in vitro (3:53)  Invertebrate models of AD (8:41)  Transgenic AD models (14:48)  Other AD models (22:47) -------------------------------------------------------------- To find the numbered bibliography with all the papers covered in this episode, click here, or use the link below:https://drive.google.com/file/d/1AhVNaKgG3KqNDwAqyNQzBvKl8ugbBntd/view?usp=share_linkTo access the folder with ALL our bibliographies, follow this link (it will be updated as we publish episodes and process bibliographies), or use the link below:https://drive.google.com/drive/folders/1bzSzkY9ZHzzY8Xhzt0HZfZhRG1Gq_Si-?usp=sharingYou can also find all of our bibliographies on our website: amindr.com. --------------------------------------------------------------Follow-up on social media for more updates!Twitter: @AMiNDR_podcastInstagram: @AMiNDR.podcastFacebook:  AMiNDR  Youtube: AMiNDR PodcastLinkedIn: AMiNDR PodcastEmail: amindrpodcast@gmail.com  -------------------------------------------------------------- Please help us spread the word about AMiNDR to your friends, colleagues, and networks! And if you could leave us a rating and/or review on your streaming app of choice (Apple Podcasts, Spotify, or wherever you listen to the podcast), that would be greatly appreciated! It helps us a lot and we thank you in advance for leaving a review! Don't forget to subscribe to hear about new episodes as they come out too. Thank you to our sponsor, the Canadian Consortium of Neurodegeneration in Aging, or CCNA, for their financial support of this podcast. This helps us to stay on the air and bring you high quality episodes. You can find out more about the CCNA on their website: https://ccna-ccnv.ca/. Our team of volunteers works tirelessly each month to bring you every episode of AMiNDR. This episode was scripted, hosted, and edited by Anusha Kamesh, and reviewed by Naila Kuhlmann. The bibliography was made by Anjana Rajendran and the wordcloud was created by Lara Onbasi (www.wordart.com). Big thanks to the sorting team for taking on the enormous task of sorting all of the Alzheimer's Disease papers into episodes each month. For October 2022, the sorters were Sarah Louadi, Eden Dubchak, Ben Cornish, Christy Yu, Dana Clausen, Kevin Nishimura, Salodin Al-Achkar, and Elyn Rowe. Also, props to our management team, which includes Sarah Louadi, Ellen Koch, Naila Kuhlmann, Elyn Rowe, Anusha Kamesh, Lara Onbasi, Joseph Liang, and Judy Cheng, for keeping everything running smoothly.Our music is from "Journey of a Neurotransmitter" by musician and fellow neuroscientist Anusha Kamesh; you can find the original piece and her other music on soundcloud under Anusha Kamesh or on her YouTube channel, AKMusic.   https://www.youtube.com/channel/UCMH7chrAdtCUZuGia16FR4w   -------------------------------------------------------------- If you are interested in joining the team, send us your CV by email. We are specifically looking for help with sorting abstracts by topic, abstract summaries and hosting, audio editing, creating bibliographies, and outreach/marketing. However, if you are interested in helping in other ways, don't hesitate to apply anyways.  --------------------------------------------------------------*About AMiNDR: *  Learn more about this project and the team behind it by listening to our first episode: "Welcome to AMiNDR!" 

PDS Biotechnology (PDSB) stock price is up over 61% this past year. PDS Biotechnology director, president, and CEO, Dr. Frank Bedu, weighs in on the latest trial results that indicated 100% clinical response for treatment of cervical cancer patients with large tumors using a combination of PDS101 with standard-of-care chemoradiotherapy. All patients had a tumor shrinkage of 60% or greater.

Arjit Jere, is a biologist, science communicator, and popular science writer based in India. Arjit has written about the lifecycle of antlions, competitor behavior in hummingbirds, climate change, and the critically endangered Amboli toad that's found only in the mountains of Western India.I met Arjit during the Science Journalism Forum, a global gathering of science journalists, communicators, and students. The forum is a virtual event, and as you know, virtual events make it possible to learn from people you would never meet otherwise. Like Arjit!  In this episode, we discuss Arjit's experiences as a science journalist and what he would like to write about next.Let's join the conversation. CLICK HERE to engage with the transcript for this episode.What do you think of this format? How does it help you relate to the guest and their work?Please share your thoughts here (https://talaterra.com/contact). LINKSArjit Jere on LinkedInArjit's blog, Nature and FootballSaevus MagazineRoundGlass SustainDr.Pankaj Koparde, Chatur Ullu Evolutionary Ecology Lab, MIT World Peace University, PuneMaharashtra Institute of Technology (MIT) World Peace UniversityCentre for Environmental Education, Pune Articles:A. Jere, Global warming and climate change - Current scenario. Biotechnology (2013) View Article A. Jere, Circle of Life, Saevus. December 2017 - February 2018, p. 66 (2017) View ArticleA. Jere, Hummingbirds and their hidden daggers. Manthan, Volume 2.2, 3 (2020) View articleA. Jere, Meet the Tiger Toad. Youth for Nature Magazine (2022). Accessed 11 Jan 2023. https://yfnmagazine.wordpress.com/2022/10/12/meet-the-tiger-toad 

In today's episode, there's a big focus on sleep in Alzheimer's disease, as well as other clinical and pharmacological studies that dive into the cognitive and behavioural deficits. We even have one paper that looks into character strengths in AD, so definitely join Judy and follow along in this unique episode from our October 2022 series!  Sections in this episode:  Sleep (2:53)  Behavioural changes in rodent models (7:00)  Behavioural changes in humans (10:02)  Cognitive changes in rodent models (14:46)  Depressive symptoms (18:09)  Other cognitive changes in humans (21:10) -------------------------------------------------------------- To find the numbered bibliography with all the papers covered in this episode, click here, or use the link below:https://drive.google.com/file/d/1Y4jHUKhkMyE5wUQgosKq1aUwQ7edV8Ps/view?usp=share_linkTo access the folder with ALL our bibliographies, follow this link (it will be updated as we publish episodes and process bibliographies), or use the link below:https://drive.google.com/drive/folders/1bzSzkY9ZHzzY8Xhzt0HZfZhRG1Gq_Si-?usp=sharingYou can also find all of our bibliographies on our website: amindr.com. --------------------------------------------------------------Follow-up on social media for more updates!Twitter: @AMiNDR_podcastInstagram: @AMiNDR.podcastFacebook:  AMiNDR  Youtube: AMiNDR PodcastLinkedIn: AMiNDR PodcastEmail: amindrpodcast@gmail.com  -------------------------------------------------------------- Please help us spread the word about AMiNDR to your friends, colleagues, and networks! And if you could leave us a rating and/or review on your streaming app of choice (Apple Podcasts, Spotify, or wherever you listen to the podcast), that would be greatly appreciated! It helps us a lot and we thank you in advance for leaving a review! Don't forget to subscribe to hear about new episodes as they come out too. Thank you to our sponsor, the Canadian Consortium of Neurodegeneration in Aging, or CCNA, for their financial support of this podcast. This helps us to stay on the air and bring you high quality episodes. You can find out more about the CCNA on their website: https://ccna-ccnv.ca/. Our team of volunteers works tirelessly each month to bring you every episode of AMiNDR. This episode was scripted and hosted by Judy Cheng, edited by Chihiro Abe, and reviewed by Ellen Koch and Anusha Kamesh. The bibliography and wordcloud were created by Lara Onbasi (www.wordart.com). Big thanks to the sorting team for taking on the enormous task of sorting all of the Alzheimer's Disease papers into episodes each month. For October 2022, the sorters were Sarah Louadi, Eden Dubchak, Ben Cornish, Christy Yu, Dana Clausen, Kevin Nishimura, Salodin Al-Achkar, and Elyn Rowe. Also, props to our management team, which includes Sarah Louadi, Ellen Koch, Naila Kuhlmann, Elyn Rowe, Anusha Kamesh, Lara Onbasi, Joseph Liang, and Judy Cheng, for keeping everything running smoothly.Our music is from "Journey of a Neurotransmitter" by musician and fellow neuroscientist Anusha Kamesh; you can find the original piece and her other music on soundcloud under Anusha Kamesh or on her YouTube channel, AKMusic.   https://www.youtube.com/channel/UCMH7chrAdtCUZuGia16FR4w   -------------------------------------------------------------- If you are interested in joining the team, send us your CV by email. We are specifically looking for help with sorting abstracts by topic, abstract summaries and hosting, audio editing, creating bibliographies, and outreach/marketing. However, if you are interested in helping in other ways, don't hesitate to apply anyways.  --------------------------------------------------------------*About AMiNDR: *  Learn more about this project and the team behind it by listening to our first episode: "Welcome to AMiNDR!" 

Honoring NBC News legend Kerry Sanders as he plans to retire. Also, Future of Beauty: a glimpse into what could be the future of beauty with the use of bio-technology as it's already being used to produce insulin and some foods. Plus, Generation Next: the inspiring story behind Stephanie Pacheco a Bronx teen whose making her mark in the world of poetry as she was just named New York City's Youth Poet Laureate. And, Bill Nighy in studio 1A to talk about his role in the new drama film “Living.”